Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from SciELO through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Sleep disorders, sleepiness and traffic safety: a public health menace

Full text
Author(s):
S.R. Pandi-Perumal [1] ; J.C. Verster [2] ; L. Kayumov [3] ; A.D. Lowe [4] ; M.G. Santana [5] ; M.L.N. Pires [6] ; S. Tufik [7] ; M.T. Mello [8]
Total Authors: 8
Affiliation:
[1] Mount Sinai School of Medicine. Division of Pulmonary, Critical Care, and Sleep Medicine - Estados Unidos
[2] University of Utrecht. Utrecht Institute for Pharmaceutical Sciences. Department of Psychopharmacology
[3] University of Toronto, and Sleep and Neuropsychiatry Institute. Department of Psychiatry - Canadá
[4] University of Toronto, and Sleep and Neuropsychiatry Institute. Department of Psychiatry - Canadá
[5] Universidade Federal de São Paulo. Departamento de Psicobiologia - Brasil
[6] Universidade Federal de São Paulo. Departamento de Psicobiologia - Brasil
[7] Universidade Federal de São Paulo. Departamento de Psicobiologia - Brasil
[8] Universidade Federal de São Paulo. Departamento de Psicobiologia - Brasil
Total Affiliations: 8
Document type: Journal article
Source: Brazilian Journal of Medical and Biological Research; v. 39, n. 7, p. 863-871, 2006-07-00.
Abstract

Sleep disorders are not uncommon and have been widely reported throughout the world. They have a profound impact on industrialized 24-h societies. Consequences of these problems include impaired social and recreational activities, increased human errors, loss of productivity, and elevated risk of accidents. Conditions such as acute and chronic insomnia, sleep loss, excessive sleepiness, shift-work, jet lag, narcolepsy, and sleep apnea warrant public health attention, since residual sleepiness during the day may affect performance of daily activities such as driving a car. Benzodiazepine hypnotics and zopiclone promote sleep, both having residual effects the following day including sleepiness and reduced alertness. In contrast, the non-benzodiazepine hypnotics zolpidem and zaleplon have no significant next-day residual effects when taken as recommended. Research on the effects of wakefulness-promoting drugs on driving ability is limited. Countermeasures for excessive daytime sleepiness have a limited effect. There is a need for a social awareness program to educate the public about the potential consequences of various sleep disorders such as narcolepsy, sleep apnea, shift-work-related sleep loss, and excessive daytime sleepiness in order to reduce the number of sleep-related traffic accidents. (AU)

FAPESP's process: 98/14303-3 - Center for Sleep Studies
Grantee:Sergio Tufik
Support Opportunities: Research Grants - Research, Innovation and Dissemination Centers - RIDC